Bjorn Scheffler

9PUBLICATIONS
79CO-AUTHORS
Haematological tumoursCellular immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 07, 2026
Distribution and prognostic significance of myelotoxicity in newly diagnosed glioblastoma in a real-life cohort: Time to treat more aggressively?

Christoph Oster, Pia Reineck, Teresa Schmidt

|Jul 31, 2024
Cranioencephalic functional lymphoid units in glioblastoma.

Celia Dobersalske, Laurèl Rauschenbach, Yichao Hua

|Oct 09, 2023
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022.

Christoph Oster, Teresa Schmidt, Sarina Agkatsev

|Aug 07, 2023
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.

Teresa Schmidt, Sarina Agkatsev, Jonas Feldheim

|Jun 19, 2023
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.

Miriam Ratliff, Kianush Karimian-Jazi, Dirk C Hoffmann

|Oct 14, 2022
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.

Sied Kebir, Vivien Ullrich, Pia Berger

Pageof 2

Frequent Collaborators

5 joint publications

Laurèl Rauschenbach

4 joint publications

Martin Glas

4 joint publications

Ulrich Sure

3 joint publications

Celia Dobersalske